The Jupiter trial--new territory for statins?
Wheeler
David C
DC
Centre for Nephrology, Royal Free Campus, University College London Medical School, London, UK. d.wheeler@medsch.ucl.ac.uk
D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium